Document:

exv10w57

EXHHIBIT 10.57

RESTRICTIVE COVENANT AGREEMENT

          THIS RESTRICTIVE COVENANT AGREEMENT (the “Agreement”), effective as of August 18, 2011,
between Michael Finke (“Shareholder”) and MedQuist Holdings Inc., a Delaware corporation (the
“Company”).

          WHEREAS, pursuant to that certain Agreement and Plan of Merger and Reorganization, dated July
11, 2011, by and among the Company, Multimodal Technologies, Inc., a Pennsylvania corporation
(“Multimodal”) and certain other parties thereto (the “Merger Agreement”), the Company will acquire
Multimodal (the “Transaction”), and all of the issued and outstanding capital stock of Multimodal
shall be converted into the right to receive the consideration set forth in the Merger Agreement;

          WHEREAS, in connection with the Transaction, Shareholder will receive significant money and
other property in exchange for Shareholder’s equity securities of Multimodal;

          WHEREAS, Shareholder acknowledges that the Company would not enter into the Merger Agreement
or complete the Transaction unless Shareholder agrees to be bound by the restrictive covenants set
forth in this Agreement and that, accordingly, Shareholder is entering into this Agreement to
induce the Company to enter into the Merger Agreement and consummate the Transaction.

          NOW, THEREFORE, in consideration of the foregoing and the mutual covenants and promises
contained herein, and intending to be bound hereby, the parties agree as follows:

     1. Definitions. Capitalized terms used herein that are not defined where used shall
have the meanings ascribed to them below:

          1.1. “Affiliate” shall have the meaning set forth in the Merger Agreement.

          1.2. “Closing Date” shall have the meaning set forth in the Merger Agreement.

          1.3. “Company Group” means, collectively and individually, the Company and each of its
Subsidiaries.

          1.4. “Competing Business” means any Person involved, anywhere in the world, in, for the
purpose of creating patient records or supplementing existing patient records, selling or reselling
technology products for use in the transcription of speech or in providing natural language
processing of text or in selling software-based solutions designed to provide means to capture,
interpret or analyze clinical data using speech recognition, speech understanding or natural
language processing capabilities.

          1.5. “Person” means any individual, firm, corporation, partnership, limited liability company,
trust, joint venture, association, governmental entity, unincorporated entity or other entity.

 

 

          1.6. “Restricted Period” means the period beginning on the Closing Date and ending on the
fifth (5th) anniversary of the Closing Date.

     2. Restrictive Covenants. To induce the Company to enter into the Merger Agreement
and to consummate the Transaction, and in recognition of the substantial money and property which
Shareholder shall receive in exchange for his equity ownership interests in Multimodal upon
consummation of the Transaction, Shareholder shall be bound by the provisions of this Section 2
(the “Restrictive Covenants”).

          2.1. Covenant Not To Compete. During the Restricted Period, Shareholder shall not,
directly or indirectly, own, manage, join, operate, participate in or otherwise be engaged in any
Competing Business. For purposes of this Section, (i) “participate” includes any direct or
indirect interest in any enterprise, whether as a stockholder, partner, joint venturer or otherwise
or rendering any direct or indirect service or assistance (including as a creditor for money
borrowed) to any Person, and (ii) ownership of voting securities of an entity whose securities are
publicly traded on a recognized securities exchange or quotation system not, in the aggregate, in
excess of two percent (2%) of such voting securities shall not be considered to be owning,
managing, joining, operating, participating in or otherwise being engaged in any Competing
Business. Shareholder acknowledges that this covenant is reasonably designed to protect the
Company’s substantial investment in Multimodal and is reasonable with respect to its duration,
geographical area and scope. For the avoidance of doubt, any employee, manager or officer of any
member of the Company Group shall not be considered to be participating in any Competing Business
in violation of this Section 2.1 in carrying out his or her activities on behalf of the Company
Group within his or her authority.

          2.2. Covenant Not To Solicit. During the Restricted Period, Shareholder shall not,
directly or indirectly:

               2.2.1. cause, solicit, induce or encourage, or attempt to cause, solicit, induce or encourage,
any actual or prospective customer, supplier or independent contractor of any member of the Company
Group (including any existing or former customer, supplier or independent contractor of any member
of the Company Group and any Person that becomes a customer, supplier or independent contractor of
any member of the Company Group on or after the Closing Date), or any other Person who has a
business relationship with any member of the Company Group, to terminate, modify or not establish
any such actual or prospective relationship;

               2.2.2. (a) cause, solicit, induce or encourage, or attempt to cause, solicit, induce or
encourage, any employee or other Person providing service to any member of the Company Group to
leave such employment or service, or (b) hire, employ or otherwise engage any employee, former
employee or other Person that provided service to any member of the Company Group during the
immediately preceding twelve (12) month period; provided that the foregoing shall not prohibit any
general solicitation or advertising activities not targeted at any such Person.

     3. Acknowledgements. Shareholder acknowledges that the restrictions on Shareholder’s
activities under this Agreement constitute a material inducement to the

 

 

consummation of the Transaction, and Shareholder further acknowledges, stipulates and agrees
that a breach of any of the obligations and agreements set forth in this Agreement will result in
irreparable harm and continuing damage to the Company Group for which there will be no adequate
remedy at law and further agrees that in the event of any breach of said obligations and
agreements, the Company and its successors and assigns will be entitled to injunctive relief and to
such other relief as is proper under the circumstances.

     4. Remedies and Enforcement Upon Breach.

          4.1. Specific Enforcement. Shareholder acknowledges that any breach by Shareholder,
willfully or otherwise, of the Restrictive Covenants will cause continuing and irreparable injury
to the Company Group for which monetary damages would not be an adequate remedy. Shareholder shall
not, in any action or proceeding to enforce any of the provisions of this Agreement, assert the
claim or defense that such an adequate remedy at law exists. In the event of any such breach by
Shareholder of any of the Restrictive Covenants, the Company shall be entitled to injunctive or
other similar equitable relief in any court, without any requirement that a bond or other security
be posted, and this Agreement shall not in any way limit remedies of law or in equity otherwise
available to the Company.

          4.2. Judicial Modification. If any court determines that any of the Restrictive
Covenants, or any part thereof, is unenforceable because of the duration or geographical scope of
such provision, such court shall have the power to modify such provision and, in its modified form,
such provision shall then be enforceable.

          4.3. Accounting. If Shareholder breaches any of the Restrictive Covenants, the
Company will have the right and remedy to require Shareholder to account for and pay over to the
Company all compensation, profits, monies, accruals, increments or other benefits derived or
received by Shareholder as the result of such breach. This right and remedy will be in addition
to, and not in lieu of, any other rights and remedies available to the Company under law or in
equity.

          4.4. Enforceability. If any court holds the Restrictive Covenants unenforceable by
reason of their breadth or scope or otherwise, it is the intention of the parties hereto that such
determination not bar or in any way affect the right of the Company to the relief provided above in
the courts of any other jurisdiction within the breadth or scope of such Restrictive Covenants.

          4.5. Disclosure of Restrictive Covenants. Shareholder shall promptly disclose the
existence and terms of the Restrictive Covenants to any Person that Shareholder may be employed by
or provide services to during the Restricted Period.

          4.6. Extension of Restricted Period. If Shareholder breaches this Agreement in any
respect, the restrictions contained in that section will be extended for a period equal to the
period that Shareholder was in breach.

     5. Miscellaneous.

          5.1. Other Agreements. Shareholder represents and warrants to the Company that there
are no restrictions, agreements or understandings whatsoever to which Shareholder is a

 

 

party that would prevent or make unlawful Shareholder’s execution of this Agreement, that
would be inconsistent or in conflict with this Agreement or Shareholder’s obligations hereunder, or
that would otherwise prevent, limit or impair the performance by Shareholder of Shareholder’s
duties under this Agreement.

          5.2. Successors and Assigns. The Company may assign this Agreement to any successor
to all or substantially all of its assets and business by means of liquidation, dissolution,
merger, consolidation, transfer of assets, or otherwise. The duties and obligations of Shareholder
hereunder are personal to Shareholder and may not be assigned by Shareholder.

          5.3. Governing Law and Forum. This Agreement shall be governed by and construed in
accordance with the laws of the State of New York, without regard to the principles of conflicts of
laws. Any legal proceeding arising out of or relating to this Agreement will be instituted in a
state or federal court in the State of New York, and Shareholder and the Company hereby consent to
the personal and exclusive jurisdiction of such court(s) and hereby waive any objection(s) that
they may have to personal jurisdiction, the laying of venue of any such proceeding and any claim or
defense of inconvenient forum.

          5.4. Waivers. The waiver by either party of any right hereunder or of any breach by
the other party will not be deemed a waiver of any other right hereunder or of any other breach by
the other party. No waiver will be deemed to have occurred unless set forth in a writing. No
waiver will constitute a continuing waiver unless specifically stated, and any waiver will operate
only as to the specific term or condition waived.

          5.5. Severability. Whenever possible, each provision and term of this Agreement shall
be interpreted in a manner to be effective and valid, but if any provision or term of this
Agreement is held to be prohibited or invalid, then such provision or term will be ineffective only
to the extent of such prohibition or invalidity, without invalidating or affecting in any manner
whatsoever the remainder of such provision or term or the remaining provisions or terms of this
Agreement. If any of the covenants set forth in this Agreement are held to be unreasonable,
arbitrary or against public policy, such covenants will be considered divisible with respect to
scope, time and geographic area, and in such lesser scope, time and geographic area, will be
effective, binding and enforceable against Shareholder.

          5.6. Survival. The obligations contained in this Agreement shall survive the
termination of any relationship between Shareholder and the Company Group.

          5.7. Entire Agreement; Amendments. This Agreement contains the entire agreement and
understanding of the parties hereto relating to the subject matter hereof, and merges and
supersedes all prior and contemporaneous discussions, agreements and understandings of every nature
relating to the subject matter, other than any employment agreement between any member of the
Company Group and Shareholder and that certain Restrictive Stock Award Agreement dated on or about
the date hereof between the Shareholder and the Company. This Agreement may not be changed or
modified, except by an agreement in writing signed by each of the parties hereto.

 

 

          5.8. Section Headings. The headings of sections and paragraphs of this Agreement are
inserted for convenience only and will not affect the meaning or construction of any provision of
this Agreement.

          5.9. Counterparts; Facsimile. This Agreement may be executed in multiple counterparts
(including by facsimile signature), each of which will be deemed to be an original, but all of
which together will constitute but one and the same instrument.

[This space left blank intentionally; signature page follows]

 

 

          IN WITNESS WHEREOF, the Company has caused this Agreement to be executed by its duly
authorized officer, and Shareholder has executed this Agreement, in each case as of the date
indicated below.

	 	 	 	 	 
	 	MEDQUIST HOLDINGS INC.

 	 
	 	By:  	/s/ Tony James
 	 
	 	 	Title:      Chief Financial Officer 	 
	 	 	Date:      August 18, 2011	 
	 
	 	SHAREHOLDER

 	 
	 	/s/ Michael Finke
 	 
	 	Date: July 11, 2011exv10w58

Exhibit 10.58

EMPLOYMENT AGREEMENT

     EMPLOYMENT AGREEMENT (the “Agreement”) dated August 18, 2011 by and between MedQuist Holdings
Inc. (the “Company”) and Juergen Fritsch (“Executive”).

     WHEREAS, Executive is currently employed by Multimodal Technologies, Inc., a Pennsylvania
corporation (“Multimodal”); and

     WHEREAS, pursuant to that certain Agreement and Plan of Merger and Reorganization, dated July
11, 2011, by and among the Company, Multimodal and certain other parties thereto (the “Merger
Agreement”), the Company will acquire Multimodal (the “Transaction”);

     WHEREAS, in connection with the Transaction, Executive will transfer to employment with the
Company and the Company and Executive desire to enter into an agreement memorializing the terms of
Executive’s employment following completion of the Transaction; and

     NOW, THEREFORE, in consideration of the premises and mutual covenants herein and for other
good and valuable consideration, the parties agree as follows:

     1. Position.

          a. The Company shall employ Executive, and Executive hereby accepts employment with the
Company, as Chief Scientist in accordance with the terms of this Agreement, effective upon
completion of the Transaction. Executive’s primary place of employment will be in the Pittsburgh,
Pennsylvania metropolitan area, subject to reasonable business travel in the course of performing
Executive’s duties for the Company. In such position, Executive shall report directly to the CEO
of the Company or his delegate and shall have such duties and responsibilities as are incident to
such position and such other executive-level duties and responsibilities as may be reasonably
assigned to Executive. For avoidance of doubt, this Agreement will be void ab initio if the
Transaction is not consummated.

          b. While Executive is employed by the Company, Executive will devote Executive’s full business
time and best efforts to the performance of Executive’s duties hereunder and will not engage in any
other business, profession or occupation for compensation or otherwise, without the prior written
consent of the Company; provided that nothing in this Agreement shall be construed as preventing
the Executive from: (i) investing the Executive’s assets in any company or other entity in a
manner not prohibited by Section ý7 hereof and in such form or manner as shall not
require any material activities on the Executive’s part in connection with the operations or
affairs of the companies or other entities in which such investments are made; or (ii) engaging in
industry, religious, charitable or other community or non-profit
activities that do not interfere, impair or conflict with the Executive’s ability to fulfill
the Executive’s duties and responsibilities under this Agreement.

     2. Base Salary. While Executive is employed by the Company, the Company shall pay
Executive a base salary at the annual rate of $180,000, payable in regular installments in
accordance with the Company’s usual payment practices. Executive shall be entitled to such
increases in Executive’s base salary, if any, as determined from time to time by the Board of

-1-

 

Directors of the Company. Executive’s annual base salary, as in effect from time to time, is
hereinafter referred to as the “Base Salary.”

     3. Annual Bonus. Commencing with fiscal year 2012, Executive will be eligible to
participate in the Company’s management incentive plan in effect for the applicable year. The
target amount of Executive’s annual bonus (“Annual Bonus”) under such plan will be 30% of
Executive’s Base Salary for the applicable year (“Target Annual Bonus”). The determination and
payment of any Annual Bonus will be subject to the terms and conditions of such plan, as in effect
for the applicable year. For fiscal year 2011, to the extent Executive remains employed through
the end of that fiscal year, Executive shall be eligible to receive a prorated portion of the
Target Annual Bonus based upon the number of days Executive was employed by the Company during such
year.

     4. Restricted Stock Grant. As an inducement to the Executive’s employment with the
Company, the Executive has been granted 78,358 restricted shares in the Company. The restricted
shares will be subject to the terms and conditions of the restricted stock award agreement attached
hereto as Exhibit A.

     5. Employee Benefits. While Executive is employed by the Company, Executive shall be
entitled to participate in the Company’s employee benefit plans as in effect from time to time
(collectively “Employee Benefits”), on the same basis as those benefits are made available to other
senior executives of the Company with equivalent levels of seniority. While Executive is employed
by the Company, Executive shall be entitled to a number of paid vacation days per calendar year
that is commensurate with other senior executives of the Company with equivalent levels of
seniority, which vacation days will accrue and may be used in accordance with the Company’s
vacation policies in effect from time to time. In addition to vacation time, Executive shall be
entitled to reasonable paid time off commensurate with Executive’s position with the Company,
including Company-recognized holidays, sick days and personal days. For the avoidance of doubt, in
calculating Executive’s seniority for purposes of determining Executive’s number of paid vacation
days per calendar year, Executive shall be credited with the service he performed with Multimodal.

     6. Business Expenses. Reasonable business expenses incurred by Executive in the
performance of Executive’s duties hereunder shall be reimbursed by the Company in accordance with
Company policies.

     7. Termination. This Agreement and Executive’s employment hereunder may be terminated
by either party at any time and for any reason; provided that Executive will be required to give
the Company at least 60 days’ advance written notice of any resignation of Executive’s employment.
Notwithstanding anything to the contrary, the provisions of this
Section 7 shall govern Executive’s rights upon termination of employment with the Company and
its affiliates.

-2-

 

          a. By the Company For Cause or By Executive Without Good Reason.

               (i) This Agreement and Executive’s employment hereunder may be terminated by the Company for
Cause (as defined below), and Executive may resign employment without Good Reason (as defined in
Section 7(c)).

               (ii) For purposes of this Agreement, “Cause” shall mean (A) Executive’s willful failure to
substantially perform Executive’s duties hereunder (other than as a result of total or partial
incapacity due to physical or mental illness) for a period of 30 days following written notice by
the Company to Executive of such failure (provided, however, that it is expressly understood that
the Executive’s failure to meet performance targets or objectives for the Annual Bonus or otherwise
shall not constitute grounds for a “Cause” termination), (B) Executive’s commission of a material
act in the performance of Executive’s duties that Executive knows to be dishonest, (C) during the
course of Executive’s employment with the Company, Executive’s conviction of, or plea of nolo
contendere to, a crime constituting (x) a felony under the laws of the United States or any
state thereof or (y) a misdemeanor involving moral turpitude (other than, in each case, a crime
arising from motor vehicle operation), (D) Executive’s willful malfeasance or willful misconduct in
connection with Executive’s duties hereunder, (E) Executive’s willful act or omission in derogation
of Executive’s duties hereunder which is demonstrably injurious to the financial condition or
business reputation of the Company or any of its subsidiaries (collectively, the “Company Group”),
(F) Executive’s material breach of any written agreement with any member of the Company Group,
which is not cured within 30 days after receipt of the written notice from the Company (provided,
however, breaches by Executive of the Merger Agreement, that certain Joinder attached to the Merger
Agreement as Exhibit B, that certain Restrictive Covenant Agreement attached to the Merger
Agreement as Exhibit J and that certain Stockholders’ Agreement attached to the Merger Agreement as
Exhibit K will only constitute breaches for purposes of this clause (F) if committed in his
individual capacity after the closing of the Transaction), or (G) Executive’s commission of an act
constituting insider trading or willful commission of an act constituting sexual harassment.

               (iii) If Executive’s employment is terminated by the Company for Cause, or if Executive
resigns without Good Reason, Executive shall be entitled to receive:

               (A) the Base Salary through the date of termination;

               (B) reimbursement, within 60 days following submission by Executive to the Company of
appropriate supporting documentation, for any unreimbursed business expenses properly incurred
by Executive in accordance with Company policy prior to the date of Executive’s termination;
provided claims for such reimbursement (accompanied by appropriate supporting documentation) are
submitted to the Company within 90 days following the date of Executive’s termination of
employment; and

               (C) such Employee Benefits, if any, as to which Executive may be entitled under the
employee benefit plans of the Company (the amounts described in clauses (A) through (C) hereof
being referred to as the “Accrued Rights”).

-3-

 

     Following such termination of Executive’s employment by the Company for Cause or resignation
by Executive without Good Reason, except as set forth in this Section 7(a)(iii), Executive shall
have no further rights to any compensation or any other benefits under this Agreement or any other
arrangement.

          b. Disability or Death.

               (i) This Agreement and Executive’s employment hereunder shall terminate upon Executive’s death
and may be terminated by the Company if Executive becomes physically or mentally incapacitated and
is therefore unable for a period of six (6) consecutive months or for an aggregate of nine (9)
months in any eighteen (18) consecutive month period to perform Executive’s duties (such incapacity
is hereinafter referred to as “Disability”). Any question as to the existence of the Disability of
Executive as to which Executive and the Company cannot agree shall be determined in writing by a
qualified independent physician mutually acceptable to Executive and the Company. If Executive and
the Company cannot agree as to a qualified independent physician, each shall appoint such a
physician and those two physicians shall select a third who shall make such determination in
writing. The determination of Disability made in writing to the Company and Executive by such
physician shall be final and conclusive for all purposes of the Agreement.

               (ii) Upon termination of Executive’s employment hereunder for either Disability or death,
Executive or Executive’s estate (as the case may be) shall be entitled to receive the Accrued
Rights, as well as a pro rata portion of the Annual Bonus, if any, that Executive would have been
entitled to receive pursuant to Section 3 hereof in such year based upon the percentage of the
fiscal year that shall have elapsed through the date of Executive’s termination of employment,
payable when such Annual Bonus would have otherwise been payable to Executive pursuant to Section 3
had Executive’s employment not been terminated (the “Pro Rata Bonus”). Following Executive’s
termination of employment due to death or Disability, except as set forth in this Section 7(b)(ii),
Executive shall have no further rights to any compensation or any other benefits under this
Agreement.

          c. By the Company Without Cause or Resignation by Executive for Good Reason.

               (i) This Agreement and Executive’s employment hereunder may be terminated by the Company
without Cause or by Executive’s resignation for Good Reason.

               (ii) For purposes of this Agreement, “Good Reason” shall mean (A) the failure of the Company
to pay or cause to be paid Executive’s Base Salary, when due hereunder, or any earned annual bonus,
when due under the terms of the applicable bonus plan, (B) any reduction in Executive’s Base Salary
or target annual bonus opportunity, (C) any substantial and sustained (i) diminution in Executive’s
authority, title, reporting relationship or responsibilities from, or (ii) assignment of duties and
responsibilities materially inconsistent
with, those described in Section 1(a) hereof, (D) relocation of the Executive’s primary place
of employment outside of the Pittsburgh, Pennsylvania metropolitan area or (E) the Company’s
material breach of this Agreement; provided that any of the events described in clauses (A)
through (E) of this Section 7(c)(ii) shall constitute Good Reason only if (x) Executive notifies
the

-4-

 

Company in writing that an event constituting Good Reason has occurred, which notice shall be
provided within 90 days after Executive first becomes aware of the occurrence of such event
constituting Good Reason, (y) the Company fails to cure such event within 30 days after receipt of
the written notice from Executive, and (z) Executive resigns employment within 90 days following
expiration of the Company’s cure period.

               (iii) If Executive’s employment is terminated by the Company without Cause (other than by
reason of death or Disability) or if Executive resigns for Good Reason (provided that in either
such case Executive does not immediately thereafter commence employment with a member of the
Company Group), Executive shall be entitled to receive:

               (A) the Accrued Rights;

               (B) any Annual Bonus otherwise earned, but unpaid, as of the date of termination for the
immediately preceding fiscal year;

               (C) the Pro Rata Bonus; and

               (D) continued payment of the Base Salary in accordance with the Company’s normal payroll
practices, as in effect on the date of termination of Executive’s employment, for a period of 12
months (the “Salary Continuation Payments”).

The payments described in paragraphs (B), (C) and (D), above (the “Severance Benefits”), are
subject to subject to Executive’s continued compliance with the provisions of Sections 8 and 9,
Executive’s execution and delivery of a general release of claims in favor of the Company and its
affiliates in the form attached hereto as Exhibit B and to such release becoming effective
and irrevocable prior to the expiration of the 60-day period immediately following the date on
which Executive’s employment terminates (such 60-day period, the “Release Period”). The Salary
Continuation Payments will commence on the first regularly scheduled payroll date following
expiration of the applicable revocation period set forth in the general release of claims, if any,
provided the Executive’s release has become irrevocable; and provided further that if the Release
Period begins in one taxable year and ends in a second taxable year, the Salary Continuation
Payments will commence on the first regularly scheduled payroll date that occurs in the second
taxable year. The bonuses described in paragraphs (B) and (C) will in each case be paid when the
Annual Bonus would have otherwise been paid to Executive for the applicable year, had his
employment not terminated (or, if later, on the first regularly scheduled payroll date that follows
the Release Period). If the release fails to become effective and irrevocable prior to the
expiration of the Release Period, the Severance Benefits will then be forfeited.

Following Executive’ s termination of employment by the Company without Cause (other than by reason
of Executive’ s death or Disability) or by Executive’s resignation for Good Reason, except as set
forth in this Section 7(c)(iii), Executive shall have no further rights to any compensation or any
other benefits under this Agreement or any other arrangement.

          d. Notice of Termination. Any purported termination of employment by the Company or
by Executive (other than due to Executive’s death) shall be communicated by written Notice of
Termination to the other party hereto in accordance with Section 11(h) hereof. For purposes of
this Agreement, a “Notice of Termination” shall mean a notice which shall

-5-

 

indicate the specific
termination provision in this Agreement relied upon and shall set forth in reasonable detail as is
available the facts and circumstances claimed to provide a basis for termination of employment
under the provision so indicated.

          e. Resignation of All Company Group Titles and Positions. Upon termination of
Executive’s employment for any reason, Executive agrees to resign, as of the date of such
termination and to the extent applicable, from any and all titles, positions and authorities that
Executive holds with any member of the Company Group.

     8. Non-Solicitation and Non-Competition.

          a. Executive acknowledges and recognizes the highly competitive nature of the businesses of
the Company Group and accordingly agrees as follows:

               (i) While Executive is performing services for the Company Group and for a period of one year
following the date Executive ceases to perform services for the Company Group for any reason (the
“Restricted Period”), Executive will not, whether on Executive’s own behalf or on behalf of or in
conjunction with any person, firm, partnership, joint venture, association, corporation or other
business organization, entity or enterprise whatsoever (“Person”) engaged in a Competitive
Business, directly or indirectly solicit or assist in soliciting the business of any client or
prospective client:

               (A) with whom Executive had personal contact or dealings on behalf of the Company Group
during the one-year period preceding the Relevant Date (as defined below);

               (B) with whom employees reporting to Executive have had personal contact or dealings on
behalf of the Company Group during the one-year period preceding the Relevant Date; or

               (C) for whom Executive had direct or indirect responsibility during the one-year period
preceding the Relevant Date.

For purposes of this Agreement, “Relevant Date” will mean (i) during the time Executive is
performing services for the Company Group, the date on which such definition is being applied for
purposes of interpreting this Section 8(a); and (ii) following any cessation of Executive’s
service, the date of such cessation.

               (ii) During the Restricted Period, Executive will not directly or indirectly:

               (A) engage in any medical transcription processing services and dictation business, any
medical speech recognition or natural language understanding technology, or other business that
competes with the business of any member of the Company
Group (including, without limitation, businesses which any member of the Company Group has
specific plans to conduct in the future and as to which Executive is aware of such planning) (a
“Competitive Business”) in any geographical area where any member of the Company Group
manufactures, produces, sells, leases, rents, licenses or otherwise provides

-6-

 

its products or
services for a Competitive Business; provided, however, that it is expressly understood and
agreed that where a Person or company is engaged in a Competitive Business, but has a
department, division or business unit that is not engaged in a Competitive Business, Executive
may take employment or provide services to such department, division or business unit and it
shall not be construed as a violation of this Section 8(a), provided that Executive has no
involvement with any portion of the business conducted by such Person or entity that is a
Competitive Business;

               (B) enter the employ of, or render any services to, any Person (or any division or
controlled or controlling affiliate of any Person) who or which engages in a Competitive
Business;

               (C) acquire a financial interest in, or otherwise become actively involved with, any
Competitive Business, directly or indirectly, as an individual, partner, shareholder, officer,
director, principal, agent, trustee or consultant; or

               (D) interfere with, or attempt to interfere with, business relationships (whether formed
before, on or after the date of this Agreement) between any member of the Company Group or any
of their respective affiliates, customers, clients, suppliers or investors.

               (iii) Notwithstanding anything to the contrary in this Agreement, Executive may, directly or
indirectly own, solely as an investment, securities of any Person engaged in the business of any
member of the Company Group that are publicly traded on a national or regional stock exchange or on
the over-the-counter market so long as Executive (i) is not a controlling person of, or a member of
a group which controls, such person and (ii) does not, directly or indirectly, own 2% or more of
any class of securities of such Person.

               (iv) During the Restricted Period, Executive will not, whether on Executive’s own behalf or on
behalf of or in conjunction with any Person, directly or indirectly:

               (A) solicit or encourage any employee of any member of the Company Group to leave
employment; or

               (B) hire any Person who was employed by any member of the Company Group as of the date of
Executive’s cessation of service or who left the employment of any member of the Company Group
during the one-year period preceding the Relevant Date.

               (v) During the Restricted Period, Executive will not, directly or indirectly, solicit or
encourage to cease to work with any member of the Company Group any consultant then under contract
with any member of the Company Group.

          b. It is expressly understood and agreed that although Executive and the Company consider the
restrictions contained in this Section 7 to be reasonable, if a final judicial determination is
made by a court of competent jurisdiction that the time or territory or any other restriction
contained in this Agreement is an unenforceable restriction against Executive, the provisions of
this Agreement shall not be rendered void but shall be deemed amended to apply as

-7-

 

to such maximum
time and territory and to such maximum extent as such court may judicially determine or indicate to
be enforceable. Alternatively, if any court of competent jurisdiction finds that any restriction
contained in this Agreement is unenforceable, and such restriction cannot be amended so as to make
it enforceable, such finding shall not affect the enforceability of any of the other restrictions
contained herein.

     9. Confidentiality; Intellectual Property.

          a. Confidentiality.

               (i) Executive will not at any time (whether during or after Executive’s employment with the
Company) (x) retain or use for the benefit, purposes or account of Executive or any other Person;
or (y) disclose, divulge, reveal, communicate, share, transfer or provide access to any Person
outside the Company (other than its professional advisers who are bound by confidentiality
obligations and other than as may be reasonable and appropriate when Executive is carrying out in
good faith Executive’s duties hereunder on behalf of the Company), any non-public, proprietary or
confidential information —including without limitation trade secrets, know-how, research and
development, software, databases, inventions, processes, formulae, technology, designs and other
intellectual property, information concerning finances, investments, profits, pricing, costs,
products, services, vendors, customers, clients, partners, investors, personnel, compensation,
recruiting, training, advertising, sales, marketing, promotions, government and regulatory
activities and approvals — concerning the past, current or future business, activities and
operations of the Company Group and/or any third party that has disclosed or provided any of same
to any member of the Company Group on a confidential basis (“Confidential Information”) without the
prior written authorization of the Company.

               (ii) “Confidential Information” shall not include any information that is (a) available to the
industry or the public other than as a result of Executive’s breach of this covenant or any breach
of other confidentiality obligations by third parties; (b) made legitimately available to Executive
by a third party without breach of any confidentiality obligation; or (c) required by law to be
disclosed; provided that Executive shall give prompt written notice to the Company of such
requirement, disclose no more information than is so required, and cooperate with any attempts by
the Company to obtain a protective order or similar treatment.

               (iii) Except as required by law, Executive will not disclose to anyone, other than Executive’s
immediate family and legal or financial advisors, the existence or contents of this Agreement;
provided that Executive may disclose to any prospective future employer the provisions of
Sections 8 and 9 of this Agreement provided they agree to maintain the confidentiality of such
terms.

               (iv) Upon termination of Executive’s employment with the Company for any reason, Executive
shall (x) cease and not thereafter commence use of any Confidential
Information or intellectual property (including without limitation, any patent, invention,
copyright, trade secret, trademark, trade name, logo, domain name or other source indicator) owned
or used by the Company Group; (y) immediately destroy, delete, or return to the Company, at the
Company’s option, all originals and copies in any form or medium (including memoranda, books,
papers, plans, computer files, letters and other data) in Executive’s

-8-

 

possession or control
(including any of the foregoing stored or located in Executive’s office, home, laptop or other
computer, whether or not Company property) that contain Confidential Information or otherwise
relate to the business of the Company Group, except that Executive may retain only those portions
of any personal notes, notebooks and diaries that do not contain any Confidential Information; and
(z) notify and fully cooperate with the Company regarding the delivery or destruction of any other
Confidential Information of which Executive is or becomes aware.

          b. Intellectual Property.

               (i) If Executive (A) has created, invented, designed, developed, contributed to or improved
any works of authorship, inventions, intellectual property, materials, documents or other work
product (including without limitation, research, reports, software, databases, systems,
applications, presentations, textual works, content, or audiovisual materials) (“Works”), either
alone or with third parties, prior to Executive’s employment by any member of the Company Group,
that are relevant to or implicated by such employment and (B) owns or has the right to grant
royalty-free licenses or sublicenses to any such Work (“Prior Works”), Executive hereby grants the
Company a perpetual, irrevocable, nonexclusive, royalty-free, worldwide, assignable, sublicensable
license under all rights and intellectual property rights (including rights under patent,
industrial property, copyright, trademark, trade secret, unfair competition and related laws)
therein for all purposes in connection with the current and future business of any member of the
Company Group.

               (ii) If Executive creates, invents, designs, develops, contributes to or improves any Works,
either alone or with third parties, at any time during Executive’s employment by any member of the
Company Group, whether pursuant to this Agreement, the Prior Employment Agreement (as defined in
Section 11(b)) or otherwise, and within the scope of such employment and/or with the use of any of
the resources of any member of the Company Group (“Company Works”), Executive shall promptly and
fully disclose same to the Company and hereby irrevocably assigns, transfers and conveys, to the
maximum extent permitted by applicable law, all rights, titles, interests and intellectual property
rights therein (including without limitation rights under patent, industrial property, copyright,
trademark, trade secret, unfair competition and related laws) (collectively, “Proprietary Rights”)
to the Company to the extent ownership of any such Proprietary Rights does not vest originally in a
member of the Company Group. To the extent any Proprietary Rights in Company Works arising under
or in connection with Executive’s employment under the Prior Employment Agreement have not fully
vested in Multimodal as of the date of this Agreement, Executive hereby assigns, transfers and
conveys all such Proprietary Rights to Multimodal.

               (iii) Executive agrees to keep and maintain adequate and current written records (in the form
of notes, sketches, drawings, and any other form or media requested
by the Company) of all Company Works. The records will be available to and remain the sole
property and intellectual property of the Company at all times.

               (iv) Executive shall take all requested actions and execute all requested documents (including
any licenses or assignments required by a government contract) at the Company’s expense (but
without further remuneration) to assist the Company in validating,

-9-

 

maintaining, protecting,
enforcing, perfecting, recording, patenting or registering any of the Company’s rights in the Prior
Works and Company Works. If the Company is unable for any reason to secure Executive’s signature
on any document for this purpose, then Executive hereby irrevocably designates and appoints the
Company and its duly authorized officers and agents as Executive’s agent and attorney in fact, to
act for and in Executive’s behalf and stead to execute any documents and to do all other lawfully
permitted acts in connection with the foregoing. Company will attempt to secure Executive’s
signature on each document for this purpose, before acting as Executive’s agent and attorney in
fact, regardless of whether Company acted as such on prior occasions.

               (v) Executive shall not improperly use for the benefit of, bring to any premises of, divulge,
disclose, communicate, reveal, transfer or provide access to, or share with the Company any
confidential, proprietary or non-public information or intellectual property relating to a former
employer (other than any member of the Company Group) or other third party without the prior
written permission of such third party. Executive hereby indemnifies, holds harmless and agrees to
defend the Company and its officers, directors, partners, employees, agents and representatives
from any breach of the foregoing covenant. Executive shall comply with all relevant policies and
guidelines of the Company Group that have been communicated or made available in writing (including
by electronic transmission) to Executive, including regarding the protection of confidential
information and intellectual property and potential conflicts of interest. Executive acknowledges
that the Company Group may amend any such policies and guidelines from time to time, and that
Executive remains at all times bound by their most current version.

               (vi) The provisions of Section 9 shall survive the termination of Executive’s employment for
any reason.

     10. Specific Performance. Executive acknowledges and agrees that the Company’s
remedies at law for a breach or threatened breach of any of the provisions of Section 7 or Section
8 would be inadequate and the Company would suffer irreparable damages as a result of such breach
or threatened breach. In recognition of this fact, Executive agrees that, in the event of such a
breach or threatened breach, in addition to any remedies at law, the Company, without posting any
bond, shall be entitled to obtain equitable relief in the form of specific performance, temporary
restraining order, temporary or permanent injunction or any other equitable remedy which may then
be available. In addition, in the event of any breach of Section 8 or Section 9, in addition to
any remedies at law, the Company, without posting any bond, shall be entitled to cease making any
payments or providing any benefit otherwise required by this Agreement (which payments shall be
deemed permanently forfeited if it is established that Executive breached Section 8 or Section 9).

     11. Miscellaneous.

          a. Governing Law. This Agreement shall be governed by and construed in accordance
with the laws of the State of Delaware, without regard to conflicts of laws principles thereof.

-10-

 

          b. Entire Agreement/Amendments. This Agreement contains the entire agreement and
understanding of the parties hereto relating to the subject matter hereof, and merges and
supersedes all prior and contemporaneous discussions, agreements and understandings of every nature
relating to the subject matter hereof, including but not limited to that certain employment
agreement between Executive and Multimodal, dated January 2002 (the “Prior Employment Agreement”).
Notwithstanding anything to the contrary, this Agreement will not supersede that certain Restricted
Stock Agreement dated on or about the closing date of the Transaction, that certain Restrictive
Covenant Agreement dated on or about the closing date of the Transaction, between Executive and the
Company (the “Restrictive Covenant Agreement”) or any other restrictive covenant made by Executive
to any member of the Company Group. This Agreement may not be altered, modified, or amended except
by written instrument signed by the parties hereto.

          c. No Waiver. The failure of a party to insist upon strict adherence to any term of
this Agreement on any occasion shall not be considered a waiver of such party’s rights or deprive
such party of the right thereafter to insist upon strict adherence to that term or any other term
of this Agreement.

          d. Severability. In the event that any one or more of the provisions of this
Agreement shall be or become invalid, illegal or unenforceable in any respect, the validity,
legality and enforceability of the remaining provisions of this Agreement shall not be affected
thereby.

          e. Assignment. This Agreement, and all of Executive’s rights and duties hereunder,
shall not be assignable or delegable by Executive. Any purported assignment or delegation by
Executive in violation of the foregoing shall be null and void ab initio and of no force and
effect. Subject to provisions herein, this Agreement may be assigned by the Company to a person or
entity which is an affiliate or a successor in interest to substantially all of the business
operations of the Company. Upon such assignment, the rights and obligations of the Company
hereunder shall become the rights and obligations of such affiliate or successor person or entity.

          f. Compliance with IRC Section 409A.

               (i) If a termination giving rise to payments and benefits hereunder is not a “Separation from
Service” within the meaning of Treas. Reg. § 1.409A-1(h)(1) (or any successor provision), then the
amounts otherwise payable pursuant to that section will instead be deferred without interest and
will not be paid until Executive experiences a Separation from Service. In addition, to the extent
compliance with the requirements of Treas. Reg. § 1.409A-3(i)(2) (or any successor provision) is
necessary to avoid the application of an additional tax under Section 409A of the Internal Revenue
Code of 1986, as amended (the “Code”), to payments due to Executive upon or following his
Separation from Service, then notwithstanding any other provision of this Agreement (or any
otherwise applicable plan, policy, agreement or
arrangement), any such payments that are otherwise due within six months following Executive’s
Separation from Service (taking into account the preceding sentence of this paragraph) will be
deferred without interest and paid to Executive in a lump sum immediately following that six month
period.

-11-

 

               (ii) This Section 10(f) should not be construed to prevent the application of Treas. Reg. §
1.409A-1(b)(9)(iii) (or any successor provision) to amounts payable hereunder. For purposes of the
application of Treas. Reg. § 1.409A-1(b)(4) (or any successor provision), each payment in a series
of payments will be deemed a separate payment.

               (iii) Notwithstanding anything herein to the contrary, to the extent any expense,
reimbursement or in-kind benefit provided to Executive constitutes a “deferral of compensation”
within the meaning of Section 409A of the Code, (i) the amount of expenses eligible for
reimbursement or in-kind benefits provided to Executive during any calendar year will not affect
the amount of expenses eligible for reimbursement or in-kind benefits provided to Executive in any
other calendar year, (ii) the reimbursements for expenses for which Executive is entitled to be
reimbursed shall be made on or before the last day of the calendar year following the calendar year
in which the applicable expense is incurred and (iii) the right to payment or reimbursement or
in-kind benefits hereunder may not be liquidated or exchanged for any other benefit.

          g. Indemnification. The Company shall maintain directors and officers liability
insurance in commercially reasonable amounts (as reasonably determined by the Board), and the
Executive shall be covered under such insurance to the same extent as any other senior executive of
the Company. In addition, the Company shall, to the maximum extent provided by the Company’s
Charter, Bylaws or standing or other resolutions, defend, indemnify and hold harmless the Executive
from and against any and all claims made against the Executive concerning or relative to his
service, actions or omissions on behalf of the Company as an officer, employee, director or agent
thereof.

          h. Successors; Binding Agreement. This Agreement shall inure to the benefit of and be
binding upon personal or legal representatives, executors, administrators, heirs, distributees,
devisees and legatees.

          i. Notice. For the purpose of this Agreement, notices and all other communications
provided for in the Agreement shall be in writing and shall be deemed to have been duly given when
delivered by hand or overnight courier or three days after it has been mailed by United States
registered mail, return receipt requested, postage prepaid, addressed to the respective addresses
set forth below in this Agreement, or to such other address as either party may have furnished to
the other in writing in accordance herewith, except that notice of change of address shall be
effective only upon receipt.

If to the Company:

MedQuist Holdings, Inc.

Attn: General Counsel

9009 Carothers Parkway, Suite C-2

Franklin, TN 37067

If to Executive:

-12-

 

To the most recent address of Executive set forth in the personnel records
of the Company.

          j. Executive Representation. Executive hereby represents to the Company that the
execution and delivery of this Agreement by Executive and the performance by Executive of
Executive’s duties hereunder shall not constitute a breach of, or otherwise contravene, the terms
of any agreement or policy to which Executive is a party or otherwise bound.

          k. Cooperation. Executive shall provide Executive’s reasonable cooperation in
connection with any action or proceeding (or any appeal from any action or proceeding) which
relates to events occurring during Executive’s employment. The Company shall exercise commercially
reasonable efforts to schedule and limit its need for Executive’s cooperation under this paragraph
so as not to interfere with Executive’s other personal and professional commitments. To the extent
such cooperation is requested and required by the Company, the Company agrees to reimburse
Executive for his reasonable out-of-pocket costs and expenses actually incurred in connection with
providing such cooperation, so long as such expenses are approved in advance by the Company, which
approval will not be unreasonably withheld. To the extent Executive’s cooperation is requested and
required by the Company pursuant to this paragraph after the first anniversary of the date
Executive’s employment with the Company ceases, the Company agrees to reimburse Executive for his
time (at a daily rate of $1,000), provided that the Company shall not be obligated to reimburse
Executive for time spent providing immaterial and incidental support to the Company. This provision
shall survive any termination of this Agreement.

          l. Withholding Taxes. Any member of the Company Group shall have the right and is
hereby authorized to deduct applicable withholding taxes from any payment or transfer of property
to Executive.

          m. Counterparts. This Agreement may be signed in counterparts, each of which shall be
an original, with the same effect as if the signatures thereto and hereto were upon the same
instrument.

[signature page follows]

-13-

 

     IN WITNESS WHEREOF, the parties hereto have duly executed this Agreement, in each case on the
date indicated below, respectively.

	 	 	 	 	 	 	 
	COMPANY

	 	 	 	EXECUTIVE	 	 
	 
	 	 	 	 	 	 
	/s/ Tony James

	 	 	 	/s/ Juergen Fritsch	 	 
	By: Anthony James

	 	 	 	By: Juergen Fritsch	 	 
	Title: Chief Financial Officer

	 	 	 	Date: 7-12-2011	 	 
	Date: August 18, 2011
	 	 	 	 	 	 

-14-

 

EXHIBIT A

MEDQUIST HOLDINGS INC.

RESTRICTED STOCK AWARD AGREEMENT

     THIS RESTRICTED STOCK AWARD AGREEMENT (this “Award” or “Agreement”) is made by
and between MedQuist Holdings Inc. (the “Company”) and Juergen Fritsch (the
“Grantee”) as of this __ day of August, 2011 (the “Effective Date”).

          WHEREAS, pursuant to that certain Agreement and Plan of Merger and Reorganization, dated July
11, 2011, by and among the Company, Multimodal Technologies, Inc., a Pennsylvania corporation
(“Multimodal”) and certain other parties thereto, the Company acquired Multimodal (the
“Transaction”); and

     WHEREAS, in order to induce the Grantee to join the employ of the Company in connection with
the Transaction, and to further align the Grantee’s financial interests with those of the Company’s
stockholders, the Board approved this Award of shares of common stock of the Company subject to the
restrictions and on the terms and conditions contained in this Agreement (the “Restricted
Stock”); and

     WHEREAS, this Award of Restricted Stock is intended to constitute a non-plan based “inducement
grant,” as described in the Nasdaq Listing Rule 5635(c)(4).

     NOW, THEREFORE, in consideration of these premises and the agreements set forth herein, the
parties, intending to be legally bound hereby, agree as follows:

     12. Award of Restricted Shares.

          a. The Company hereby awards the Grantee 78,358 shares of Restricted Stock
(the “Restricted Shares”).

          b. The Company maintains the MedQuist Holdings Inc. 2010 Equity Incentive Plan (the
“Plan”), which provides the general terms and restrictions for certain equity incentive
awards to the Company’s employees, directors, consultants, and other individuals who provide
services to the Company. This Award of Restricted Stock is not awarded pursuant to the Plan, but
rather is intended to constitute a non-plan based “inducement grant,” as described in Nasdaq
Listing Rule 5635(c)(4). Nonetheless, the terms and provisions of the Plan relating to restricted
stock (including, without limitation, Section 9 of the Plan) are hereby incorporated into this
Agreement by this reference, as though fully set forth herein, as if the Restricted Shares were
granted pursuant to the Plan. Unless the context herein otherwise requires, the terms defined in
the Plan shall have the same meanings herein.

     13. Vesting of Restricted Shares. The Restricted Shares are subject to
forfeiture to the Company until they become vested and non-forfeitable in accordance with this
Section 2. While subject to forfeiture, the Restricted Shares may not be sold, pledged, assigned,
otherwise encumbered or transferred in any manner, whether voluntarily or involuntarily by the
operation of law, except to (i) an immediate family member or (ii) a trust or other estate-planning
vehicle (collectively, the “Permitted Transferees”), so long as any such Permitted
Transferee, as a condition to such transfer, agrees in writing to be bound by the terms of this
Agreement with respect to the Restricted Shares.

          a. 100% of the Restricted Shares subject hereto shall become vested and
non-forfeitable on the third anniversary of the Effective Date, provided the Grantee remains in
continuous service with the Company through such date.

          
A-1

 

          b. Upon cessation of the Service Relationship (hereinafter defined), any Restricted
Shares which then remain forfeitable (determined after application of Section 2(c), below) will
immediately and automatically, without any action on the part of the Company, be forfeited, and the
Grantee will have no further rights with respect to those shares.

          c. If the Service Relationship (as defined below) terminates due to the
Grantee’s death, or if a Change in Control (as defined below) occurs during the Service
Relationship, any otherwise unvested Restricted Shares will then become vested and non-forfeitable.
Similarly, if the Service Relationship ceases due to a termination by the Company without
“Cause”, due to the Grantee’s “Disability” or due to a resignation by the Grantee
with “Good Reason” (each as defined in that certain Employment Agreement between the
Grantee and the Company dated on or about the closing date of the Transaction (the “Employment
Agreement”)), and the Grantee executes a release of claims in the form and manner described in
Section 7(c)(iii) of the Employment Agreement within the timeframe established in the Employment
Agreement, any otherwise unvested Restricted Shares will become vested and non-forfeitable when
such release becomes irrevocable.

          d. For purposes of this Agreement, “Service Relationship” means the
Grantee’s employment or service with the Company or its parent or any subsidiary or Affiliate,
whether in the capacity of an employee, director or a consultant. Unless otherwise determined by
the Board, the Grantee’s Service Relationship shall not be deemed to have terminated merely because
of a change in the capacity in which the Grantee renders service to the Company or a transfer
between locations of the Company, its parent or any subsidiary or Affiliate or a transfer between
the Company, its parent, or any subsidiary or Affiliate, provided that there is no interruption or
other termination of the Service Relationship. Subject to the foregoing and the following
sentence, the Company, in its discretion, shall determine whether the Grantee’s Service
Relationship has terminated and the effective date of such termination. The following events shall
not be deemed a termination of the Service Relationship:

               (i) an approved leave of absence for sickness, or for any other purpose approved by
the Board; provided, however, that if any such leave exceeds ninety (90) days, then
on the ninety-first (91st) day of such leave, the Grantee’s Service Relationship shall
be deemed to have terminated unless the Grantee’s right to return to service is guaranteed either
by a statute or by contract; and

               (ii) notwithstanding the foregoing, unless otherwise designated by the Board or
required by law, a leave of absence shall not be treated as service for purposes of determining
vesting under this Agreement.

          e. For purposes of this Agreement, the term “Change in Control” means the
occurrence of any one of the following:

               (i) Any “person” (as such term is used in Sections 13(d) and 14(d) of the Securities
Exchange Act of 1934, as amended), other than (a) a trustee or other fiduciary holding securities
under an employee benefit plan of the Company or any of its subsidiaries, (b) a corporation owned
directly or indirectly by the shareholders of the Company in substantially the same proportions as
their ownership of stock of the Company, or (c) Siris Capital Group, LLC or any of its affiliates
is or becomes the “beneficial owner” (as defined in Rule 13d-3 under said Exchange Act), directly
or indirectly, of securities of the Company by reason of having acquired such securities during the
twelve month period ending on the date of the most recent acquisition (not including any securities
acquired directly from the Company) representing 50% or more of the total combined voting power of
the Company’s then outstanding voting securities (the “Voting Stock”);

A-2

 

               (ii) the majority of members of the Board is replaced during any 12-month period by
directors whose appointment or election is not endorsed by a majority of the members of the Board
before the date of the appointment or election; or

               (iii) consummation of a reorganization, merger or consolidation resulting in a
change described in (i) or (ii) of this definition, or the sale or other disposition of all or
substantially all of the assets of the Company involving 50% or more of the total gross fair market
value of all of the assets of the Company immediately before such sale of assets (a “Business
Combination”), in each case, unless all or substantially all of the individuals and entities who
were the beneficial owners, respectively, of the Voting Stock immediately prior to such Business
Combination beneficially own, directly or indirectly, more than 50% of the total voting power
represented by the voting securities entitled to vote generally in the election of directors of the
corporation resulting from the Business Combination in substantially the same proportions as their
ownership, immediately prior to the Business Combination of the Voting Stock of the Company.

     14. Issuance of Shares.

          a. The Company will cause the Restricted Shares to be issued in the Grantee’s name
either by book-entry registration or issuance of a stock certificate or certificates.

          b. While the Restricted Shares remain forfeitable, the Company will cause an
appropriate stop-transfer order to be issued and to remain in effect with respect to the Restricted
Shares. As soon as practicable following the time that any Restricted Share becomes nonforfeitable
(and provided that appropriate arrangements have been made with the Company for the withholding or
payment of any taxes that may be due with respect to such share), the Company will cause that
stop-transfer order to be removed. The Company may also condition delivery of certificates for
Restricted Shares upon receipt from the Grantee of any undertakings, customarily requested of other
similarly situated recipients of restricted stock awards from the Company, that it may promptly
determine are appropriate to facilitate compliance with federal and state securities laws.

          c. If any certificate is issued in respect of Restricted Shares, that certificate
will be legended and held in escrow by the Company or an agent of the Company. In addition, the
Grantee may be required to execute and deliver to the Company a stock power with respect to those
Restricted Shares. At such time as those Restricted Shares become nonforfeitable, the Company will
cause a new certificate to be issued without that portion of the legend referencing the previously
applicable forfeiture conditions and will promptly cause that new certificate to be delivered to
the Grantee (provided that appropriate arrangements have been made with the Company for the
withholding or payment of any taxes that may be due with respect to such shares).

     15. Substitute Property. If, while any of the Restricted Shares remain
subject to forfeiture, there occurs a merger, reclassification, recapitalization, stock split,
stock dividend or other similar event or transaction resulting in new, substituted or additional
securities being issued or delivered to the Grantee by reason of the Grantee’s ownership of the
Restricted Shares, such securities will constitute “Restricted Shares” for all purposes of
this Agreement and any certificate issued to evidence such securities will immediately be deposited
with the secretary of the Company (or his or her designee) and subject to the escrow described in
Section 3, above.

     16. Rights of Grantee During Restricted Period. The Grantee will have the
right to vote the Restricted Shares and to receive dividends and distributions with respect to the
Restricted Shares; provided, however, that any cash dividends or distributions paid in respect of
the Restricted Shares while

A-3

 

those shares remain subject to forfeiture will be withheld by the Company and will be
delivered to the Grantee (without interest and net of any required tax withholding) only if and
when the Restricted Shares giving rise to such dividends or distributions become vested and
non-forfeitable.

     17. Securities Laws. The Board may from time to time impose any conditions
on the Restricted Shares as it deems necessary or advisable to ensure that the Restricted Shares
are issued and sold in compliance with the requirements of any stock exchange or quotation system
upon which the shares are then listed or quoted, the Securities Act of 1933 and all other
applicable laws.

     18. Tax Consequences.

          a. The Grantee acknowledges that the Company has not advised the Grantee regarding
the Grantee’s income tax liability in connection with the grant or vesting of the Restricted
Shares. The Grantee has had the opportunity to review with his or her own tax advisors the
federal, state and local tax consequences of the transactions contemplated by this Agreement. The
Grantee is relying solely on such advisors and not on any statements or representations of the
Company or any of its agents. The Grantee understands that the Grantee (and not the Company) shall
be responsible for the Grantee’s own tax liability that may arise as a result of the transactions
contemplated by this Agreement.

          b. If the Grantee makes an election under Section 83(b) of the Code with respect to
the grant of the Restricted Shares, the Grantee agrees to notify the Company in writing on the day
of such election. The amount includible in the Grantee’s income as a result of that election will
be subject to tax withholding. The Grantee will be required to remit to the Company in cash, or
make other arrangements reasonably satisfactory to the Company for the satisfaction of such tax
withholding amount; failure to do so within five business days of making the Section 83(b) election
will result in forfeiture of all the Restricted Shares.

     19. The Plan. Although this Award of Restricted Stock is not granted under
the Plan, the terms of the Plan have been incorporated herein by reference. Accordingly, the
Grantee agrees to be bound by all of the terms and conditions of the Plan, as such Plan may be
amended from time to time in accordance with the terms thereof; provided, that no amendment to the
Plan after the date hereof which adversely affects the Grantee’s rights hereunder or interest in
the Restricted Shares will be binding on the Grantee without the Grantee’s prior written agreement
(other than any such amendment which is required under applicable law or rules of the national
market system on which the Company’s securities are traded). This Award of Restricted Stock will
be administered by the Board or its designated Committee, who will have the same authority with
respect to this Award of Restricted Stock as described in Section 4 of the Plan. A copy of the
Plan in its present form has been provided to the Grantee on or prior to the date hereof. All
questions regarding the interpretation of the terms of this Award of Restricted Stock, including
all questions regarding the application and interpretation of Plan provisions incorporated herein,
will be determined by the Board or its designated Committee, whose determination will be final,
binding and conclusive.

     20. Covenant Not to Solicit.

          a. While the Grantee is in service to the Company (or any of its subsidiaries or
Affiliates), and for one year following cessation of the Grantee’s service to the Company (or any
of its subsidiaries or Affiliates) for any reason, the Grantee shall not, directly or indirectly:

               (i) cause, solicit, induce or encourage, or attempt to cause, solicit, induce or
encourage, any actual or prospective customer, supplier or independent contractor of the Company or
any
of its subsidiaries or Affiliates (including any existing or former customer, supplier or
independent

A-4

 

contractor of the Company or any of its subsidiaries or Affiliates and any Person that
becomes a customer, supplier or independent contractor of the Company or any of its subsidiaries or
Affiliates on or after the date of termination of the Grantee’s service to the Company or any of
its subsidiaries or Affiliates), or any other Person who has a business relationship with the
Company or any of its subsidiaries or Affiliates, to terminate, modify or not establish any such
actual or prospective relationship;

               (ii) cause, solicit, induce or encourage, or attempt to cause, solicit, induce or
encourage, any employee or other Person providing service to the Company or any of its subsidiaries
or Affiliates, or any employee or other Person providing service to the Company or any of its
subsidiaries or Affiliates during the immediately preceding rolling twelve (12) month period, to
leave such employment or service, or hire, employ or otherwise engage any such Person; provided
that the foregoing shall not prohibit any general solicitation or advertising activities not
targeted at any such Person.

          b. Acknowledgements. The Grantee acknowledges that the Restricted Shares
would not be granted in the absence of the Grantee’s agreement to this Section 9.

          c. Specific Enforcement. The Grantee acknowledges that any breach by the
Grantee, willfully or otherwise, of this Section 9 will cause continuing and irreparable injury to
the Company and its subsidiaries and Affiliates for which monetary damages would not be an adequate
remedy. The Grantee shall not, in any action or proceeding to enforce any of the provisions of
this Section 9, assert the claim or defense that such an adequate remedy at law exists. In the
event of any such breach by the Grantee of any of the provisions of this Section 9, the Company
shall be entitled to injunctive or other similar equitable relief in any court, without any
requirement that a bond or other security be posted, and this Agreement shall not in any way limit
remedies of law or in equity otherwise available to the Company.

          d. Accounting. If the Grantee breaches any of the provisions of this
Section 9, the Company will have the right and remedy to require the Grantee to account for and pay
over to the Company all compensation, profits, monies, accruals, increments or other benefits
derived or received by the Grantee as the result of such breach. This right and remedy will be in
addition to, and not in lieu of, any other rights and remedies available to the Company under law
or in equity.

          e. Enforceability in Multiple Jurisdictions. If any court holds the
provisions of this Section 9 unenforceable, it is the intention of the parties hereto that such
determination not bar, or in any way affect, the right of the Company to the relief herein provided
in the courts of any other jurisdiction.

          f. Disclosure and Extension of Restrictive Covenants. The Grantee shall
promptly disclose the existence and terms of this Section 9 to any party that the Grantee may be
employed by or provide services to while the restrictions of this Section 9 remain in effect. If
the Grantee breaches this Agreement in any respect, the restrictions contained in that section will
be extended for a period equal to the period that the Grantee was in breach.

          g. Survival. The obligations contained in this Section 9 shall survive the
cessation of any relationship between the Grantee and the Company or its subsidiaries or
Affiliates.

          h. Successors and Assigns. The Company may assign its rights under Section
9 of this Agreement to any successor to all or substantially all of its assets and business by
means of liquidation, dissolution, merger, consolidation, transfer of assets, or otherwise. The
duties and obligations of the Grantee hereunder are personal to the Grantee and may not be assigned
by the Grantee.

A-5

 

     21. Consent to Electronic Delivery. The Grantee hereby authorizes the
Company to deliver electronically any prospectuses or other documentation related to this
Agreement, the Plan and any other compensation or benefit plan or arrangement in effect from time
to time (including, without limitation, reports, proxy statements or other documents that are
required to be delivered to participants in such plans or arrangements pursuant to federal or state
laws, rules or regulations). For this purpose, electronic delivery will include, without
limitation, delivery by means of e-mail or e-mail notification that such documentation is available
on the Company’s intranet site. Upon written request, the Company will provide to the Grantee a
paper copy of any document also delivered to the Grantee electronically. The authorization
described in this paragraph may be revoked by the Grantee at any time by written notice to the
Company.

     22. Entire Agreement. This Agreement, including the terms incorporated
herein by reference, represents the entire agreement between the parties hereto relating to the
subject matter hereof, and merges and supersedes all prior and contemporaneous discussions,
agreements and understandings of every nature relating to the subject matter hereof.
Notwithstanding anything to the contrary, this Agreement will not supersede any other restrictive
covenant agreement between the Grantee and the Company or any of its Affiliates and the Grantee
shall be bound both by the restrictions set forth in such other restrictive covenants agreements
and the restrictions set forth in this Agreement.

     23. Severability. Whenever possible, each provision and term of this
Agreement shall be interpreted in a manner to be effective and valid, but if any provision or term
of this Agreement is held to be prohibited or invalid, then such provision or term will be
ineffective only to the extent of such prohibition or invalidity, without invalidating or affecting
in any manner whatsoever the remainder of such provision or term or the remaining provisions or
terms of this Agreement. If any of the covenants set forth in this Agreement are held to be
unreasonable, arbitrary or against public policy, such covenants will be considered divisible with
respect to scope, time and geographic area, and in such lesser scope, time and geographic area,
will be effective, binding and enforceable against the Grantee.

     24. Governing Law. This Agreement shall be governed by and construed in
accordance with the laws of the State of Delaware, without regard to the principles of conflicts of
laws. Any legal proceeding arising out of or relating to this Agreement will be instituted in a
state or federal court in the State of Delaware, and the Grantee and the Company hereby consent to
the personal and exclusive jurisdiction of such court(s) and hereby waive any objection(s) that
they may have to personal jurisdiction, the laying of venue of any such proceeding and any claim or
defense of inconvenient forum.

     25. Amendment. This Agreement may only be amended by a writing signed by
each of the parties hereto.

     26. Execution. This Agreement may be executed, including execution by
facsimile signature, in one or more counterparts, each of which will be deemed an original, and all
of which together shall be deemed to be one and the same instrument.

     27. Clawback.

          a. Grantee’s Conduct. Notwithstanding anything to the contrary contained
herein, if the Company as a result of misconduct or fraud is required to prepare a financial
restatement due to the material noncompliance of the Company with any financial reporting
requirement under the securities laws, where the Grantee (i) engaged in fraud resulting in such
financial restatement, or (ii) knowingly or through gross negligence engaged in misconduct
resulting in such financial restatement, the Grantee shall forfeit any or all of the Restricted
Shares, whether or not vested, then held by the Grantee and repay to the

A-6

 

Company an amount in cash equal to all or any portion of the sales proceeds received by the
Grantee in connection with the sale or other disposition of any such Restricted Shares during the
three-year period preceding the date on which the Company first determines that it must prepare the
financial restatement (or, if no proceeds were received by the Grantee in any such disposition, an
amount equal to the aggregate fair market value of the Restricted Shares so disposed of, determined
as of the date of such disposition). For the avoidance of doubt, the Grantee’s failure to have
personal knowledge of the conduct of any other individual that contributed to a financial
restatement shall not, in and of itself, be sufficient to trigger this provision.

          b. Conduct of Others or Errors. Notwithstanding anything to the contrary
contained herein, the Grantee shall repay the Company any amount in excess of what the Grantee
should have received under the terms of the Award for any reason (including without limitation by
reason of a financial restatement, mistake in calculation or other administrative error) with
respect to any sale or other disposition of any Restricted Shares during the three-year period
preceding the date on which the Company first determines that it must prepare the financial
restatement or otherwise first discovers the mistake or error and promptly notifies the Grantee.

          c. Compliance. The Grantee will agree to revise this Section 16 to the
extent necessary for the Company to comply with any regulatory guidance promulgated under Section
954 of the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010.

[signature page follows]

A-7

 

     IN WITNESS WHEREOF, the Company’s duly authorized representative and the Grantee have each
executed this Restricted Stock Award Agreement on the respective date below indicated.

	 	 	 	 	 
	 	MEDQUIST HOLDINGS INC.

 	 
	 	By
 	 
	 	 	 
	 	Name: 	 	 
	 	 	 
	 	Title: 	 	 
	 	 	 
	 	Date: 	 	 
	 	 	 
	 	 	 
	 	GRANTEE 	 
	 	 	 
	 	 	 
	 	Signature 	 
	 	 	 
	 	 	 
	 	Name: 	 	 
	 	 	 
	 	Date: 	 	 
	 

-0-

 

	 	 	 	 	 

EXHIBIT B

RELEASE AND NON-DISPARAGEMENT AGREEMENT

     THIS RELEASE AND NON-DISPARAGEMENT AGREEMENT (this “Release”) is made as of the ___ day of
_______, ____ by and between Juergen Fritsch (the “Executive”) and MedQuist Holdings, Inc. (the
“Company”).

     WHEREAS, the Executive’s employment as an employee of the Company has terminated; and

     WHEREAS, pursuant to Section 7(c) of the Employment Agreement by and between the
Company and the Executive dated August 18, 2011 (the “Agreement”), the Company has agreed to pay
the Executive certain amounts and to provide him with certain rights and benefits, subject to the
execution of this Release.

     NOW THEREFORE, in consideration of these premises and the mutual promises contained herein,
and intending to be legally bound hereby, the parties agree as follows:

          1. Consideration. The Executive acknowledges that: (i) the payments, rights and
benefits set forth in Section 7(c) of the Agreement constitute full settlement of all his
rights under the Agreement, (ii) he has no entitlement under any other severance or similar
arrangement maintained by the Company, and (iii) except as otherwise provided specifically in this
Release, the Company and its affiliates do not and will not have any other liability or obligation
to the Executive. The Executive acknowledges that, in the absence of his execution of this
Release, the benefits and payments specified in Section 7(c) of the Agreement would not
otherwise be due to him.

          2. Release and Covenant Not to Sue.

               The Executive fully and forever releases and discharges the Company, and all of its,
affiliates and subsidiaries, and each of their respective stockholders, predecessors, successors,
assigns, officers, directors, trustees, employees, agents and attorneys, past and present (the
Company and each such person or entity is referred to as a “Released Person”) from any and all
claims, demands, liens, agreements, contracts, covenants, actions, suits, causes of action,
obligations, controversies, debts, costs, expenses, damages, judgments, orders and liabilities, of
whatever kind or nature, direct or indirect, in law, equity or otherwise, whether known or unknown,
arising through the date of this Release, out of the Executive’s employment by the Company or the
termination thereof, including, but not limited to, any claims for relief or causes of action under
the Age Discrimination in Employment Act, 29 U.S.C. § 621 et seq., or any other federal, state or
local statute, ordinance or regulation regarding discrimination in employment and any claims,
demands or actions based upon alleged wrongful or retaliatory discharge or breach of contract under
any state or federal law.

               a. The Executive expressly represents that he has not filed a lawsuit or initiated any other
administrative proceeding against a Released Person and that he has not assigned any claim against
a Released Person. The Executive further promises not to initiate a

B-1

 

lawsuit or to bring any other claim against the other arising out of or in any way related to
the Executive’s employment by the Company or the termination of that employment. This Release will
not prevent the Executive from filing a charge with the Equal Employment Opportunity Commission (or
similar state agency) or participating in any investigation conducted by the Equal Employment
Opportunity Commission (or similar state agency); provided, however, that any claims by the
Executive for personal relief in connection with such a charge or investigation (such as
reinstatement or monetary damages) would be barred.

               b. The foregoing will not be deemed to release the Company from (a) claims solely to enforce
this Release, (b) claims solely to enforce Section 7(c) of the Agreement, or (c) claims for
indemnification under Section 11(g) of the Agreement.

          3. Restrictive Covenants. The Executive acknowledges that restrictive covenants
contained in Sections 8 and 9 of the Agreement will survive the termination of his
employment. The Executive affirms that those restrictive covenants are reasonable and necessary to
protect the legitimate interests of the Company and its affiliates, that he received adequate
consideration in exchange for agreeing to those restrictions and that he will abide by those
restrictions.

          4. Non-Disparagement. The Executive will not disparage, or otherwise take any action
which could reasonably be expected to adversely affect the personal or professional reputation of:
(i) the Company, any of its subsidiaries or any of their respective officers and directors in any
respect, or (ii) any other Released Person in the capacity in which such person is associated with
the Company. The Company’s directors and officers will not disparage Executive or otherwise take
any action which could reasonably be expected to adversely affect the personal or professional
reputation of Executive.

          5. Rescission Right. The Executive expressly acknowledges and recites that (a) he has
read and understands the terms of this Release in its entirety, (b) he has entered into this
Release knowingly and voluntarily, without any duress or coercion; (c) he has been advised orally
and is hereby advised in writing to consult with an attorney with respect to this Release before
signing it; (d) he was provided twenty-one (21) calendar days after receipt of the Release to
consider its terms before signing it; and (e) he is provided seven (7) calendar days from the date
of signing to terminate and revoke this Release, in which case this Release shall be unenforceable,
null and void. The Executive may revoke this Release during those seven (7) days by providing
written notice of revocation to the Company at the address set forth in the Agreement.

          6. Challenge. If the Executive violates any provisions of the Restrictive Covenants
or this Release, no further payments, rights or benefits under Section 7(c) of the Agreement will
be due to the Executive.

          7. Miscellaneous.

               a. No Admission of Liability. This Release is not to be construed as an admission of
any violation of any federal, state or local statute, ordinance or regulation or of

B-2

 

any duty owed by the Company to the Executive. There have been no such violations, and the
Company specifically denies any such violations.

               b. No Reinstatement. The Executive agrees that he will not apply for reinstatement
with the Company or seek in any way to be reinstated, re-employed or hired by the Company in the
future.

               c. Successors and Assigns. This Release shall inure to the benefit of and be binding
upon the Company and the Executive and their respective successors, permitted assigns, executors,
administrators and heirs. The Executive may not make any assignment of this Release or any
interest herein, by operation of law or otherwise. The Company may assign this Release to any
successor to all or substantially all of its assets and business by means of liquidation,
dissolution, merger, consolidation, transfer of assets, or otherwise.

               d. Severability. Whenever possible, each provision of this Release will be
interpreted in such manner as to be effective and valid under applicable law. However, if any
provision of this Release is held to be invalid, illegal or unenforceable in any respect, such
invalidity, illegality or unenforceability will not affect any other provision, and this Release
will be reformed, construed and enforced as though the invalid, illegal or unenforceable provision
had never been herein contained.

               e. Entire Agreement; Amendments. Except as otherwise provided herein, this Release
contains the entire agreement and understanding of the parties hereto relating to the subject
matter hereof, and merges and supersedes all prior and contemporaneous discussions, agreements and
understandings of every nature relating to the subject matter hereof. This Release may not be
changed or modified, except by an agreement in writing signed by each of the parties hereto.
Notwithstanding anything to the contrary, this Agreement will not supersede that certain Restricted
Stock Agreement dated [ ], 2011

               f. Governing Law. This Release shall be governed by, and enforced in accordance with,
the laws of the State of Delaware, without regard to the application of the principles of conflicts
of laws.

               g. Counterparts and Facsimiles. This Release may be executed, including execution by
facsimile signature, in multiple counterparts, each of which shall be deemed an original, and all
of which together shall be deemed to be one and the same instrument.

[signature page follows]

B-3

 

     IN WITNESS WHEREOF, the Company has caused this Release to be executed by its duly authorized
officer, and the Executive has executed this Release, in each case on the date first above written.

	 	 	 	 	 
	 	COMPANY

 	 
	 	By:  	 	 
	 	Name & Title: 	 	 
	 	 	 	 
	 

	 	 	 	 	 
	 	JUERGEN FRITSCH

 	 
	 	 	 
	 	 	 
	 	 	 
	 

B-4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00194-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00194-of-00352.parquet"}]]